PDF
T/CMBA 021-2023 Active
T/CMBA 021-2023 Quality Management Specification for Raw Materials Used in Cell Therapy Product Manufacturing
Abstract
Main technical content: This document sets out the quality requirements for raw materials used in the production of cell therapy products, as well as the unique characteristics and quality requirements of certain specific components or types of raw materials used in production, such as serum and serum substitutes, recombinant proteins, and tissue extract proteins, etc.
General Product Information
| Document Type | Group standards |
|---|---|
| Standard Status | Active |
| Standard Code | T/CMBA 021-2023 |
| ICS | Integrated medical science and healthcare devices |
| Implement Date | 2023-09-14 |
Price
$ 20.00
Subtotal
$ 20.00
Tax
$ 0.00
Order Total (incl. tax)
$ 20.00